4th Quarter - Report

THORN RUN PARTNERS for SUNOVION PHARMACEUTICALS INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Funding issues related to the VA Epilepsy Centers for Excellence.

LobbyistCovered position, as disclosed
CATHERINE FINLEY —
GARY PALMQUIST —
BILLY WYNNE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

DEA scheduling of pharmaceuticals

LobbyistCovered position, as disclosed
CATHERINE FINLEY —
GARY PALMQUIST —
BILLY WYNNE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017. Medicare Part D, Medicaid reform, mental and neurological health issues.

LobbyistCovered position, as disclosed
CATHERINE FINLEY —
GARY PALMQUIST —
BILLY WYNNE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.